{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:10:11Z","timestamp":1793833811907,"version":"4.6.1"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003136","name":"Edmond J. Safra Philanthropic Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100003136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["W004984"],"award-info":[{"award-number":["W004984"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer\u2019s Society","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sporadic Parkinson\u2019s disease (PD) is a progressive neurodegenerative disease, with a complex risk structure thought to be influenced by interactions between genetic variants and environmental exposures, although the full aetiology is unknown. Environmental factors, including pesticides, have been reported to increase the risk of developing the disease. Growing evidence suggests epigenetic changes are key mechanisms by which these environmental factors act upon gene regulation, in disease-relevant cell types. We present a systematic review critically appraising and summarising the current body of evidence of the relationship between epigenetic mechanisms and environmental risk factors in PD to inform future research in this area. Epigenetic studies of relevant environmental risk factors in animal and cell models have yielded promising results, however, research in humans is just emerging. While published studies in humans are currently relatively limited, the importance of the field for the elucidation of molecular mechanisms of pathogenesis opens clear and promising avenues for the future of PD research. Carefully designed epidemiological studies carried out in PD patients hold great potential to uncover disease-relevant gene regulatory mechanisms. Therefore, to advance this burgeoning field, we recommend broadening the scope of investigations to include more environmental exposures, increasing sample sizes, focusing on disease-relevant cell types, and recruiting more diverse cohorts.<\/jats:p>","DOI":"10.1038\/s41531-023-00568-z","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T13:02:55Z","timestamp":1692968575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Linking environmental risk factors with epigenetic mechanisms in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Maria","family":"Tsalenchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve M.","family":"Gentleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3924-2053","authenticated-orcid":false,"given":"Sarah J.","family":"Marzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"568_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/ijms18030551","volume":"18","author":"R Cacabelos","year":"2017","unstructured":"Cacabelos, R. Parkinson\u2019s disease: from pathogenesis to pharmacogenomics. Int. J. Mol. Sci. 18, 551 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"568_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a009282","volume":"2","author":"P Mazzoni","year":"2012","unstructured":"Mazzoni, P., Shabbott, B. & Cort\u00e9s, J. C. Motor control abnormalities in Parkinson\u2019s disease. Cold Spring Harb. Perspect. Med. 2, 1\u201317 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"568_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fneur.2018.00455","volume":"9","author":"N Gigu\u00e8re","year":"2018","unstructured":"Gigu\u00e8re, N., Nanni, S. B. & Trudeau, L. E. On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease. Front. Neurol. 9, 455 (2018).","journal-title":"Front. Neurol."},{"key":"568_CR4","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469\u20136473 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"568_CR5","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.1074\/jbc.M306390200","volume":"279","author":"E Lindersson","year":"2004","unstructured":"Lindersson, E. et al. Proteasomal inhibition by \u03b1-synuclein filaments and oligomers. J. Biol. Chem. 279, 12924\u201312934 (2004).","journal-title":"J. Biol. Chem."},{"key":"568_CR6","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1126\/science.6308771","volume":"221","author":"JE Goldman","year":"1983","unstructured":"Goldman, J. E., Yen, S. H., Chiu, F. C. & Peress, N. S. Lewy bodies of Parkinson\u2019s disease contain neurofilament antigens. Science 221, 1082\u20131084 (1983).","journal-title":"Science"},{"key":"568_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","volume":"27","author":"K Wakabayashi","year":"2007","unstructured":"Wakabayashi, K., Tanji, K., Mori, F. & Takahashi, H. The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of \u03b1-synuclein aggregates. Neuropathology 27, 494\u2013506 (2007).","journal-title":"Neuropathology"},{"key":"568_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"key":"568_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.molmed.2006.09.007","volume":"12","author":"A Wood-Kaczmar","year":"2006","unstructured":"Wood-Kaczmar, A., Gandhi, S. & Wood, N. W. Understanding the molecular causes of Parkinson\u2019s disease. Trends Mol. Med. 12, 521\u2013528 (2006).","journal-title":"Trends Mol. Med."},{"key":"568_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-017-0780-8","volume":"17","author":"A Puschmann","year":"2017","unstructured":"Puschmann, A. New genes causing hereditary parkinson\u2019s disease or parkinsonism. Curr. Neurol. Neurosci. Rep. 17, 66 (2017).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"568_CR11","doi-asserted-by":"publisher","first-page":"971252","DOI":"10.3389\/fneur.2022.971252","volume":"13","author":"LJ Smith","year":"2022","unstructured":"Smith, L. J., Lee, C. Y., Menozzi, E. & Schapira, A. H. V. Genetic variations in GBA1 and LRRK2 genes: biochemical and clinical consequences in Parkinson disease. Front. Neurol. 13, 971252 (2022).","journal-title":"Front. Neurol."},{"key":"568_CR12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/ana.25441","volume":"85","author":"SM Goldman","year":"2019","unstructured":"Goldman, S. M. et al. Concordance for Parkinson\u2019s disease in twins: a 20-year update. Ann. Neurol. 85, 600\u2013605 (2019).","journal-title":"Ann. Neurol."},{"key":"568_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat. Genet. 46, 989\u2013993 (2014).","journal-title":"Nat. Genet."},{"key":"568_CR14","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"568_CR15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1212\/01.wnl.0000256374.50227.4b","volume":"68","author":"EL Thacker","year":"2007","unstructured":"Thacker, E. L. et al. Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology 68, 764\u2013768 (2007).","journal-title":"Neurology"},{"key":"568_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ana.21717","volume":"66","author":"A Elbaz","year":"2009","unstructured":"Elbaz, A. et al. Professional exposure to pesticides and Parkinson disease. Ann. Neurol. 66, 494\u2013504 (2009).","journal-title":"Ann. Neurol."},{"key":"568_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40478-020-00924-7","volume":"8","author":"V Delic","year":"2020","unstructured":"Delic, V., Beck, K. D., Pang, K. C. H. & Citron, B. A. Biological links between traumatic brain injury and Parkinson\u2019s disease. Acta Neuropathol. Commun. 8, 45 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"568_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"568_CR19","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.aay0793","volume":"366","author":"A Nott","year":"2019","unstructured":"Nott, A. et al. Brain cell type-specific enhancer\u2013promoter interactome maps and disease-risk association. Science 366, 1134\u20131139 (2019).","journal-title":"Science"},{"key":"568_CR20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41588-020-0610-9","volume":"52","author":"J Bryois","year":"2020","unstructured":"Bryois, J. et al. Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson\u2019s disease. Nat. Genet. 52, 482\u2013493 (2020).","journal-title":"Nat. Genet."},{"key":"568_CR21","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s41588-020-00721-x","volume":"52","author":"MR Corces","year":"2020","unstructured":"Corces, M. R. et al. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer\u2019s and Parkinson\u2019s diseases. Nat. Genet. 52, 1158\u20131168 (2020).","journal-title":"Nat. Genet."},{"key":"568_CR22","doi-asserted-by":"publisher","first-page":"A160","DOI":"10.1289\/ehp.114-a160","volume":"114","author":"B Weinhold","year":"2006","unstructured":"Weinhold, B. Epigenetics: the science of change. Environ. Health Perspect. 114, A160\u2013A167 (2006).","journal-title":"Environ. Health Perspect."},{"key":"568_CR23","doi-asserted-by":"publisher","first-page":"12194","DOI":"10.1074\/jbc.M607838200","volume":"282","author":"L Lande-Diner","year":"2007","unstructured":"Lande-Diner, L. et al. Role of DNA methylation in stable gene repression. J. Biol. Chem. 282, 12194\u201312200 (2007).","journal-title":"J. Biol. Chem."},{"key":"568_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S1043-2760(00)00248-4","volume":"11","author":"J Newell-Price","year":"2000","unstructured":"Newell-Price, J., Clark, A. J. & King, P. DNA methylation and silencing of gene expression. Trends Endocrinol. Metab. 11, 142\u2013148 (2000).","journal-title":"Trends Endocrinol. Metab."},{"key":"568_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484\u2013492 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"568_CR26","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930\u2013935 (2009).","journal-title":"Science"},{"key":"568_CR27","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/nchem.2064","volume":"6","author":"M Bachman","year":"2014","unstructured":"Bachman, M. et al. 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat. Chem. 6, 1049\u20131055 (2014).","journal-title":"Nat. Chem."},{"key":"568_CR28","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.cell.2012.11.022","volume":"151","author":"M Mell\u00e9n","year":"2012","unstructured":"Mell\u00e9n, M., Ayata, P., Dewell, S., Kriaucionis, S. & Heintz, N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417\u20131430 (2012).","journal-title":"Cell"},{"key":"568_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-10-r119","volume":"14","author":"M Iurlaro","year":"2013","unstructured":"Iurlaro, M. et al. A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol. 14, R119 (2013).","journal-title":"Genome Biol."},{"key":"568_CR30","doi-asserted-by":"publisher","first-page":"919","DOI":"10.4161\/cc.4.7.1824","volume":"4","author":"JA Daniel","year":"2005","unstructured":"Daniel, J. A., Pray-Grant, M. G. & Grant, P. A. Effector proteins for methylated histones: an expanding family. Cell Cycle 4, 919\u2013926 (2005).","journal-title":"Cell Cycle"},{"key":"568_CR31","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1038\/nprot.2017.124","volume":"12","author":"J Ernst","year":"2017","unstructured":"Ernst, J. & Kellis, M. Chromatin-state discovery and genome annotation with ChromHMM. Nat. Protoc. 12, 2478\u20132492 (2017).","journal-title":"Nat. Protoc."},{"key":"568_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2020","unstructured":"Statello, L., Guo, C. J., Chen, L. L. & Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol. 22, 96\u2013118 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"568_CR33","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/life12040502","volume":"12","author":"O Kaut","year":"2022","unstructured":"Kaut, O. et al. Epigenome-wide analysis of DNA methylation in Parkinson\u2019s disease cortex. Life 12, 502 (2022).","journal-title":"Life"},{"key":"568_CR34","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4161\/epi.25865","volume":"8","author":"E Masliah","year":"2013","unstructured":"Masliah, E., Dumaop, W., Galasko, D. & Desplats, P. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 8, 1030\u20131038 (2013).","journal-title":"Epigenetics"},{"key":"568_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0466-5","volume":"9","author":"Y-H Chuang","year":"2017","unstructured":"Chuang, Y.-H. et al. Parkinson\u2019s disease is associated with DNA methylation levels in human blood and saliva. Genome Med. 9, 76 (2017).","journal-title":"Genome Med."},{"key":"568_CR36","doi-asserted-by":"publisher","first-page":"640266","DOI":"10.3389\/fgene.2021.640266","volume":"12","author":"AR Henderson","year":"2021","unstructured":"Henderson, A. R. et al. DNA methylation and expression profiles of whole blood in Parkinson\u2019s disease. Front. Genet. 12, 640266 (2021).","journal-title":"Front. Genet."},{"key":"568_CR37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JPD-181549","volume":"9","author":"Y-H Chuang","year":"2019","unstructured":"Chuang, Y.-H. et al. Longitudinal epigenome-wide methylation study of cognitive decline and motor progression in Parkinson\u2019s disease. J. Parkinsons DIS. 9, 389\u2013400 (2019).","journal-title":"J. Parkinsons DIS."},{"key":"568_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41531-022-00355-2","volume":"8","author":"J Kochmanski","year":"2022","unstructured":"Kochmanski, J., Kuhn, N. C. & Bernstein, A. I. Parkinson\u2019s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2\u03b2), and NR4A2 (NURR1) in cortical neurons. NPJ Parkinsons Dis. 8, 120 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"568_CR39","doi-asserted-by":"publisher","first-page":"e15522","DOI":"10.1371\/journal.pone.0015522","volume":"5","author":"L Matsumoto","year":"2010","unstructured":"Matsumoto, L. et al. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson\u2019s disease. PLoS One 5, e15522 (2010).","journal-title":"PLoS One"},{"key":"568_CR40","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","volume":"30","author":"A Jowaed","year":"2010","unstructured":"Jowaed, A., Schmitt, I., Kaut, O. & W\u00fcllner, U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains. J. Neurosci. 30, 6355\u20136359 (2010).","journal-title":"J. Neurosci."},{"key":"568_CR41","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/mds.24907","volume":"27","author":"J Richter","year":"2012","unstructured":"Richter, J. et al. No evidence for differential methylation of \u03b1-synuclein in leukocyte DNA of Parkinson\u2019s disease patients. Mov. Disord. 27, 590\u2013591 (2012).","journal-title":"Mov. Disord."},{"key":"568_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-017-0285-z","volume":"10","author":"S Guhathakurta","year":"2017","unstructured":"Guhathakurta, S., Evangelista, B. A., Ghosh, S., Basu, S. & Kim, Y. S. Hypomethylation of intron1 of \u03b1-synuclein gene does not correlate with Parkinson\u2019s disease. Mol. Brain 10, 1\u20136 (2017).","journal-title":"Mol. Brain"},{"key":"568_CR43","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.1074\/jbc.C110.212589","volume":"286","author":"P Desplats","year":"2011","unstructured":"Desplats, P. et al. Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J. Biol. Chem. 286, 9031\u20139037 (2011).","journal-title":"J. Biol. Chem."},{"key":"568_CR44","doi-asserted-by":"publisher","first-page":"242.e13","DOI":"10.1016\/j.neurobiolaging.2019.02.025","volume":"84","author":"L Shu","year":"2019","unstructured":"Shu, L. et al. Genetic analysis of DNA methylation and hydroxymethylation genes in Parkinson\u2019s disease. Neurobiol. Aging 84, 242.e13\u2013242.e16 (2019).","journal-title":"Neurobiol. Aging"},{"key":"568_CR45","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/15592294.2019.1588682","volume":"14","author":"A Henderson-Smith","year":"2019","unstructured":"Henderson-Smith, A. et al. DNA methylation changes associated with Parkinson\u2019s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood. Epigenetics 14, 365\u2013382 (2019).","journal-title":"Epigenetics"},{"key":"568_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10048-011-0308-3","volume":"13","author":"O Kaut","year":"2012","unstructured":"Kaut, O., Schmitt, I. & W\u00fcllner, U. Genome-scale methylation analysis of Parkinson\u2019s disease patients\u2019 brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics 13, 87\u201391 (2012).","journal-title":"Neurogenetics"},{"key":"568_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-016-0004-y","volume":"3","author":"R St\u00f6ger","year":"2017","unstructured":"St\u00f6ger, R., Scaife, P. J., Shephard, F. & Chakrabarti, L. Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson\u2019s disease. npj Parkinson\u2019s Dis. 3, 1\u20133 (2017).","journal-title":"npj Parkinson\u2019s Dis."},{"key":"568_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jchemneu.2018.12.005","volume":"96","author":"O Kaut","year":"2019","unstructured":"Kaut, O., Kuchelmeister, K., Moehl, C. & W\u00fcllner, U. 5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson\u2019s disease. J. Chem. Neuroanat. 96, 41\u201348 (2019).","journal-title":"J. Chem. Neuroanat."},{"key":"568_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-021-00450-7","volume":"16","author":"L Toker","year":"2021","unstructured":"Toker, L. et al. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain. Mol. Neurodegener. 16, 31 (2021).","journal-title":"Mol. Neurodegener."},{"key":"568_CR50","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41593-018-0253-7","volume":"21","author":"SJ Marzi","year":"2018","unstructured":"Marzi, S. J. et al. A histone acetylome-wide association study of Alzheimer\u2019s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nat. Neurosci. 21, 1618\u20131627 (2018).","journal-title":"Nat. Neurosci."},{"key":"568_CR51","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41588-020-0696-0","volume":"52","author":"R Nativio","year":"2020","unstructured":"Nativio, R. et al. An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer\u2019s disease. Nat. Genet. 52, 1024\u20131035 (2020).","journal-title":"Nat. Genet."},{"key":"568_CR52","doi-asserted-by":"publisher","first-page":"948456","DOI":"10.3389\/fnmol.2022.948456","volume":"15","author":"E Ramamurthy","year":"2023","unstructured":"Ramamurthy, E. et al. Cell type-specific histone acetylation profiling of Alzheimer\u2019s disease subjects and integration with genetics. Front. Mol. Neurosci. 15, 948456 (2023).","journal-title":"Front. Mol. Neurosci."},{"key":"568_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12061860","volume":"12","author":"CT Hong","year":"2020","unstructured":"Hong, C. T., Chan, L. & Bai, C.-H. The effect of caffeine on the risk and progression of Parkinson\u2019s disease: a meta-analysis. Nutrients 12, 1\u201312 (2020).","journal-title":"Nutrients"},{"key":"568_CR54","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1212\/WNL.58.8.1154","volume":"58","author":"MA Schwarzschild","year":"2002","unstructured":"Schwarzschild, M. A., Chen, J. F. & Ascherio, A. Caffeinated clues and the promise of adenosine A(2A) antagonists in PD. Neurology 58, 1154\u20131160 (2002).","journal-title":"Neurology"},{"key":"568_CR55","doi-asserted-by":"publisher","first-page":"E12053","DOI":"10.1073\/pnas.1813365115","volume":"115","author":"R Yan","year":"2018","unstructured":"Yan, R. et al. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson\u2019s disease and DLB. Proc. Natl Acad. Sci. USA 115, E12053\u2013E12062 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"568_CR56","doi-asserted-by":"publisher","first-page":"e95297","DOI":"10.1371\/journal.pone.0095297","volume":"9","author":"M Van Der Mark","year":"2014","unstructured":"Van Der Mark, M. et al. A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking. PLoS ONE 9, e95297 (2014).","journal-title":"PLoS ONE"},{"key":"568_CR57","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.25882","volume":"29","author":"P Derkinderen","year":"2014","unstructured":"Derkinderen, P., Shannon, K. M. & Brundin, P. Gut feelings about smoking and coffee in Parkinson\u2019s disease. Mov. Disord. 29, 976 (2014).","journal-title":"Mov. Disord."},{"key":"568_CR58","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20682","volume":"58","author":"H Chen","year":"2005","unstructured":"Chen, H. et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease. Ann. Neurol. 58, 963\u2013967 (2005).","journal-title":"Ann. Neurol."},{"key":"568_CR59","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/S1353-8020(13)70030-0","volume":"20","author":"MJ Zigmond","year":"2014","unstructured":"Zigmond, M. J. & Smeyne, R. J. Exercise: is it a neuroprotective and if so, how does it work? Parkinsonism Relat. Disord. 20, S123\u2013S127 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"568_CR60","doi-asserted-by":"publisher","first-page":"e182421","DOI":"10.1001\/jamanetworkopen.2018.2421","volume":"1","author":"X Fang","year":"2018","unstructured":"Fang, X. et al. Association of levels of physical activity with risk of Parkinson disease: a systematic review and meta-analysis. JAMA Netw. Open 1, e182421 (2018).","journal-title":"JAMA Netw. Open"},{"key":"568_CR61","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/aje\/kwm127","volume":"166","author":"MG Weisskopf","year":"2007","unstructured":"Weisskopf, M. G., O\u2019Reilly, E., Chen, H., Schwarzschild, M. A. & Ascherio, A. Plasma urate and risk of Parkinson\u2019s disease. Am. J. Epidemiol. 166, 561\u2013567 (2007).","journal-title":"Am. J. Epidemiol."},{"key":"568_CR62","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.25292","volume":"84","author":"CJ Kobylecki","year":"2018","unstructured":"Kobylecki, C. J., Nordestgaard, B. G. & Afzal, S. Plasma urate and risk of Parkinson\u2019s disease: a mendelian randomization study. Ann. Neurol. 84, 178\u2013190 (2018).","journal-title":"Ann. Neurol."},{"key":"568_CR63","doi-asserted-by":"publisher","first-page":"e12172","DOI":"10.1097\/MD.0000000000012172","volume":"97","author":"L Ren","year":"2018","unstructured":"Ren, L. et al. Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease. Medicine 97, e12172 (2018).","journal-title":"Medicine"},{"key":"568_CR64","doi-asserted-by":"publisher","first-page":"e1413","DOI":"10.1212\/WNL.0000000000005328","volume":"90","author":"E Roos","year":"2018","unstructured":"Roos, E. et al. Body mass index, sitting time, and risk of Parkinson disease. Neurology 90, e1413\u2013e1417 (2018).","journal-title":"Neurology"},{"key":"568_CR65","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/jnnp.2006.097170","volume":"77","author":"G Logroscino","year":"2006","unstructured":"Logroscino, G., Sesso, H. D., Paffenbarger, R. S. & Lee, I.-M. Physical activity and risk of Parkinson\u2019s disease: a prospective cohort study. J. Neurol. Neurosurg. Psychiatry 77, 1318\u20131322 (2006).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"568_CR66","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0006-291X(86)91210-6","volume":"137","author":"D Di Monte","year":"1986","unstructured":"Di Monte, D., Sandy, M. S., Ekstr\u00f6m, G. & Smith, M. T. Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity. Biochem. Biophys. Res. Commun. 137, 303\u2013309 (1986).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"568_CR67","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/0006-2952(96)00091-3","volume":"51","author":"KP St McNaught","year":"1996","unstructured":"St McNaught, K. P. et al. Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration. Biochem. Pharmacol. 51, 1503\u20131511 (1996).","journal-title":"Biochem. Pharmacol."},{"key":"568_CR68","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/0024-3205(89)90365-2","volume":"44","author":"CE Lambert","year":"1989","unstructured":"Lambert, C. E. & Bondy, S. C. Effects of MPTP, MPP+ and paraquat on mitochondrial potential and oxidative stress. Life Sci. 44, 1277\u20131284 (1989).","journal-title":"Life Sci."},{"key":"568_CR69","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/ije\/dyx225","volume":"47","author":"C Pouchieu","year":"2018","unstructured":"Pouchieu, C. et al. Pesticide use in agriculture and Parkinson\u2019s disease in the AGRICAN cohort study. Int. J. Epidemiol. 47, 299\u2013310 (2018).","journal-title":"Int. J. Epidemiol."},{"key":"568_CR70","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1001\/archneurol.2009.195","volume":"66","author":"CM Tanner","year":"2009","unstructured":"Tanner, C. M. et al. Occupation and risk of parkinsonism: a multicenter case-control study. Arch. Neurol. 66, 1106\u20131113 (2009).","journal-title":"Arch. Neurol."},{"key":"568_CR71","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamaneurol.2021.1335","volume":"78","author":"S Jo","year":"2021","unstructured":"Jo, S. et al. Association of NO2 and other air pollution exposures with the risk of Parkinson disease. JAMA Neurol. 78, 800\u2013808 (2021).","journal-title":"JAMA Neurol."},{"key":"568_CR72","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1289\/ehp.1409313","volume":"124","author":"B Ritz","year":"2016","unstructured":"Ritz, B. et al. Traffic-related air pollution and Parkinson\u2019s disease in Denmark: a case-control study. Environ. health Perspect. 124, 351\u2013356 (2016).","journal-title":"Environ. health Perspect."},{"key":"568_CR73","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/19338244.2018.1492894","volume":"74","author":"W Tangamornsuksan","year":"2019","unstructured":"Tangamornsuksan, W. et al. Paraquat exposure and Parkinson\u2019s disease: a systematic review and meta-analysis. Arch. Environ. Occup. Health 74, 225\u2013238 (2019).","journal-title":"Arch. Environ. Occup. Health"},{"key":"568_CR74","doi-asserted-by":"publisher","first-page":"e0151841","DOI":"10.1371\/journal.pone.0151841","volume":"11","author":"CB Breckenridge","year":"2016","unstructured":"Breckenridge, C. B., Berry, C., Chang, E. T., Sielken, R. L. Jr & Mandel, J. S. Association between Parkinson\u2019s disease and cigarette smoking, rural living, well-water consumption, farming and pesticide use: systematic review and meta-analysis. PLoS ONE 11, e0151841 (2016).","journal-title":"PLoS ONE"},{"key":"568_CR75","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/oemed-2020-106958","volume":"78","author":"X Zeng","year":"2020","unstructured":"Zeng, X., DeBono, N. L., Harris, A. M., Arrandale, V. H. & Demers, P. A. Neurodegenerative diseases among miners in Ontario, Canada, using a linked cohort. Occup. Environ. Med. 78, 385\u2013392 (2020).","journal-title":"Occup. Environ. Med."},{"key":"568_CR76","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1212\/WNL.0000000000003533","volume":"88","author":"BA Racette","year":"2017","unstructured":"Racette, B. A. et al. Dose-dependent progression of parkinsonism in manganese-exposed welders. Neurology 88, 344\u2013351 (2017).","journal-title":"Neurology"},{"key":"568_CR77","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1212\/WNL.48.3.650","volume":"48","author":"JM Gorell","year":"1997","unstructured":"Gorell, J. M. et al. Occupational exposures to metals as risk factors for Parkinson\u2019s disease. Neurology 48, 650\u2013658 (1997).","journal-title":"Neurology"},{"key":"568_CR78","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1289\/ehp.9102","volume":"114","author":"S Coon","year":"2006","unstructured":"Coon, S. et al. Whole-body lifetime occupational lead exposure and risk of Parkinson\u2019s disease. Environ. Health Perspect. 114, 1872\u20131876 (2006).","journal-title":"Environ. Health Perspect."},{"key":"568_CR79","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/mds.25125","volume":"27","author":"L Kenborg","year":"2012","unstructured":"Kenborg, L., Funch, L. C., Hansen, J. & Olsen, J. H. Parkinson\u2019s disease and other neurodegenerative disorders among welders: a Danish cohort study. Mov. Disord. 27, 1283\u20131289 (2012).","journal-title":"Mov. Disord."},{"key":"568_CR80","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1212\/01.wnl.0000184520.21744.a2","volume":"65","author":"R Frigerio","year":"2005","unstructured":"Frigerio, R. et al. Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology 65, 1575\u20131583 (2005).","journal-title":"Neurology"},{"key":"568_CR81","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/ana.22629","volume":"71","author":"SM Goldman","year":"2012","unstructured":"Goldman, S. M. et al. Solvent exposures and Parkinson disease risk in twins. Ann. Neurol. 71, 776\u2013784 (2012).","journal-title":"Ann. Neurol."},{"key":"568_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/1476-069X-13-68","volume":"13","author":"FJ Bove","year":"2014","unstructured":"Bove, F. J., Ruckart, P. Z., Maslia, M. & Larson, T. C. Mortality study of civilian employees exposed to contaminated drinking water at USMC Base Camp Lejeune: a retrospective cohort study. Environ. Health 13, 68 (2014).","journal-title":"Environ. Health"},{"key":"568_CR83","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajim.20788","volume":"53","author":"JA Firestone","year":"2010","unstructured":"Firestone, J. A. et al. Occupational factors and risk of Parkinson\u2019s disease: a population-based case\u2013control study. Am. J. Ind. Med. 53, 217\u2013223 (2010).","journal-title":"Am. J. Ind. Med."},{"key":"568_CR84","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1039\/C9EM00578A","volume":"22","author":"BR De Miranda","year":"2020","unstructured":"De Miranda, B. R. & Greenamyre, J. T. Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson\u2019s disease. Environ. Sci. Process. Impacts 22, 543\u2013554 (2020).","journal-title":"Environ. Sci. Process. Impacts"},{"key":"568_CR85","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/mds.25458","volume":"28","author":"S Jafari","year":"2013","unstructured":"Jafari, S., Etminan, M., Aminzadeh, F. & Samii, A. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov. Disord. 28, 1222\u20131229 (2013).","journal-title":"Mov. Disord."},{"key":"568_CR86","doi-asserted-by":"publisher","first-page":"e1771","DOI":"10.1212\/WNL.0000000000005522","volume":"90","author":"RC Gardner","year":"2018","unstructured":"Gardner, R. C. et al. Mild TBI and risk of Parkinson disease. Neurology 90, e1771\u2013e1779 (2018).","journal-title":"Neurology"},{"key":"568_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1212\/WNL.0000000000004057","volume":"89","author":"KC Hughes","year":"2017","unstructured":"Hughes, K. C. et al. Intake of dairy foods and risk of Parkinson disease. Neurology 89, 46\u201352 (2017).","journal-title":"Neurology"},{"key":"568_CR88","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/mds.28902","volume":"37","author":"C Domenighetti","year":"2022","unstructured":"Domenighetti, C. et al. Dairy intake and Parkinson\u2019s disease: a mendelian randomization study. Mov. Disord. 37, 857\u2013864 (2022).","journal-title":"Mov. Disord."},{"key":"568_CR89","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/mds.108","volume":"33","author":"N Gronich","year":"2018","unstructured":"Gronich, N. et al. \u03b22-adrenoceptor agonists and antagonists and risk of Parkinson\u2019s disease. Mov. Disord. 33, 1465\u20131471 (2018).","journal-title":"Mov. Disord."},{"key":"568_CR90","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ana.25341","volume":"84","author":"SS Nielsen","year":"2018","unstructured":"Nielsen, S. S., Gross, A., Camacho-Soto, A., Willis, A. W. & Racette, B. A. \u03b22-adrenoreceptor medications and risk of Parkinson disease. Ann. Neurol. 84, 683\u2013693 (2018).","journal-title":"Ann. Neurol."},{"key":"568_CR91","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1212\/WNL.0000000000001684","volume":"84","author":"H Gustafsson","year":"2015","unstructured":"Gustafsson, H., Nordstr\u00f6m, A. & Nordstr\u00f6m, P. Depression and subsequent risk of Parkinson disease. Neurology 84, 2422\u20132429 (2015).","journal-title":"Neurology"},{"key":"568_CR92","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","volume":"16","author":"E Jacob","year":"2010","unstructured":"Jacob, E., Gatto, N., Thompson, A., Bordelon, Y. & Ritz, B. Occurrence of depression and anxiety prior to Parkinson\u2019s disease. Parkinsonism Relat. Disord. 16, 576\u2013581 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"568_CR93","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-212922","volume":"12","author":"BR De Miranda","year":"2022","unstructured":"De Miranda, B. R., Goldman, S. M., Miller, G. W., Greenamyre, J. T. & Dorsey, E. R. Preventing Parkinson\u2019s disease: an environmental agenda. J. Parkinsons Dis. 12, 45\u201368 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"568_CR94","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R., Sherer, T., Okun, M. S. & Bloem, B. R. The emerging evidence of the Parkinson pandemic. J. Parkinsons Dis. 8, S3\u2013S8 (2018).","journal-title":"J. Parkinsons Dis."},{"key":"568_CR95","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","volume":"134","author":"RJ Smeyne","year":"2005","unstructured":"Smeyne, R. J. & Jackson-Lewis, V. The MPTP model of Parkinson\u2019s disease. Mol. Brain Res. 134, 57\u201366 (2005).","journal-title":"Mol. Brain Res."},{"key":"568_CR96","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1074\/jbc.M115.675488","volume":"291","author":"G Park","year":"2016","unstructured":"Park, G. et al. Regulation of histone acetylation by autophagy in Parkinson disease. J. Biol. Chem. 291, 3531\u20133540 (2016).","journal-title":"J. Biol. Chem."},{"key":"568_CR97","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.neuro.2011.05.018","volume":"32","author":"C Song","year":"2011","unstructured":"Song, C. et al. Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration. NeuroToxicology 32, 586\u2013595 (2011).","journal-title":"NeuroToxicology"},{"key":"568_CR98","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.1021\/bi0341152","volume":"42","author":"J Goers","year":"2003","unstructured":"Goers, J. et al. Nuclear localization of alpha-synuclein and its interaction with histones. Biochemistry 42, 8465\u20138471 (2003).","journal-title":"Biochemistry"},{"key":"568_CR99","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/mol.109.062174","volume":"77","author":"C Song","year":"2010","unstructured":"Song, C., Kanthasamy, A., Anantharam, V., Sun, F. & Kanthasamy, A. G. Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration. Mol. Pharmacol. 77, 621\u2013632 (2010).","journal-title":"Mol. Pharmacol."},{"key":"568_CR100","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/toxsci\/kfz069","volume":"169","author":"J Kochmanski","year":"2019","unstructured":"Kochmanski, J., Vanoeveren, S. E., Patterson, J. R. & Bernstein, A. I. Developmental dieldrin exposure alters DNA methylation at genes related to dopaminergic neuron development and Parkinson\u2019s disease in mouse midbrain. Toxicological Sci. 169, 593\u2013607 (2019).","journal-title":"Toxicological Sci."},{"key":"568_CR101","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1007\/s00204-016-1899-0","volume":"91","author":"P Tarale","year":"2017","unstructured":"Tarale, P. et al. Global DNA methylation profiling of manganese-exposed human neuroblastoma SH-SY5Y cells reveals epigenetic alterations in Parkinson\u2019s disease-associated genes. Arch. Toxicol. 91, 2629\u20132641 (2017).","journal-title":"Arch. Toxicol."},{"key":"568_CR102","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neulet.2016.05.060","volume":"627","author":"KG Gebremedhin","year":"2016","unstructured":"Gebremedhin, K. G. & Rademacher, D. J. Histone H3 acetylation in the postmortem Parkinson\u2019s disease primary motor cortex. Neurosci. Lett. 627, 121\u2013125 (2016).","journal-title":"Neurosci. Lett."},{"key":"568_CR103","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/toxsci\/kfx294","volume":"162","author":"Y Wu","year":"2018","unstructured":"Wu, Y. et al. Regulatory roles of histone deacetylases 1 and 2 in Pb-induced neurotoxicity. Toxicol. Sci. 162, 688\u2013701 (2018).","journal-title":"Toxicol. Sci."},{"key":"568_CR104","first-page":"1","volume":"17","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. Epigenetic basis of lead-induced neurological disorders. Int. J. Environ. Res. Public Health 17, 1\u201323 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"568_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0713-2","volume":"11","author":"CF Rider","year":"2019","unstructured":"Rider, C. F. & Carlsten, C. Air pollution and DNA methylation: effects of exposure in humans. Clin. Epigenetics 11, 131 (2019).","journal-title":"Clin. Epigenetics"},{"key":"568_CR106","doi-asserted-by":"publisher","first-page":"109226","DOI":"10.1016\/j.envres.2020.109226","volume":"183","author":"L Calder\u00f3n-Garcidue\u00f1as","year":"2020","unstructured":"Calder\u00f3n-Garcidue\u00f1as, L. et al. Reduced repressive epigenetic marks, increased DNA damage and Alzheimer\u2019s disease hallmarks in the brain of humans and mice exposed to particulate urban air pollution. Environ. Res. 183, 109226 (2020).","journal-title":"Environ. Res."},{"key":"568_CR107","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.tiv.2017.10.003","volume":"46","author":"P Tarale","year":"2018","unstructured":"Tarale, P. et al. Manganese exposure: linking down-regulation of miRNA-7 and miRNA-433 with alpha-synuclein overexpression and risk of idiopathic Parkinson\u2019s disease. Toxicol. Vitro 46, 94\u2013101 (2018).","journal-title":"Toxicol. Vitro"},{"key":"568_CR108","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/brainsci12020175","volume":"12","author":"E Angelopoulou","year":"2022","unstructured":"Angelopoulou, E., Paudel, Y. N., Papageorgiou, S. G. & Piperi, C. Environmental impact on the epigenetic mechanisms underlying Parkinson\u2019s disease pathogenesis: a narrative review. Brain Sci. 12, 175 (2022).","journal-title":"Brain Sci."},{"key":"568_CR109","doi-asserted-by":"crossref","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).","DOI":"10.1136\/bmj.n71"},{"key":"568_CR110","doi-asserted-by":"publisher","unstructured":"Ryan, R. & Hill, S. How to GRADE the quality of the evidence. https:\/\/doi.org\/10.26181\/5b57d95632a2c (2016).","DOI":"10.26181\/5b57d95632a2c"},{"key":"568_CR111","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/mds.25784","volume":"29","author":"KG Coupland","year":"2014","unstructured":"Coupland, K. G. et al. DNA methylation of the MAPT gene in Parkinson\u2019s disease cohorts and modulation by vitamin E in vitro. Mov. Disord. 29, 1606\u20131614 (2014).","journal-title":"Mov. Disord."},{"key":"568_CR112","doi-asserted-by":"publisher","first-page":"113135","DOI":"10.1016\/j.physbeh.2020.113135","volume":"227","author":"GSD Oliveira","year":"2020","unstructured":"Oliveira, G. S. D. et al. Effect of exercise and grape juice on epigenetic modulation and functional outcomes in PD: A randomized clinical trial. Physiol. Behav. 227, 113135 (2020).","journal-title":"Physiol. Behav."},{"key":"568_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-020-00582-4","volume":"21","author":"RCPP Go","year":"2020","unstructured":"Go, R. C. P. P. et al. Genome-wide epigenetic analyses in Japanese immigrant plantation workers with Parkinson\u2019s disease and exposure to organochlorines reveal possible involvement of glial genes and pathways involved in neurotoxicity. BMC Neurosci. 21, 31 (2020).","journal-title":"BMC Neurosci."},{"key":"568_CR114","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12640-017-9736-7","volume":"32","author":"S Castillo","year":"2017","unstructured":"Castillo, S., Mu\u00f1oz, P., Behrens, M. I., Diaz-Grez, F. & Segura-Aguilar, J. On the role of mining exposure in epigenetic effects in Parkinson\u2019s disease. Neurotox. Res. 32, 172\u2013174 (2017).","journal-title":"Neurotox. Res."},{"key":"568_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-021-01051-3","volume":"13","author":"KC Paul","year":"2021","unstructured":"Paul, K. C., Horvath, S., Del Rosario, I., Bronstein, J. M. & Ritz, B. DNA methylation biomarker for cumulative lead exposure is associated with Parkinson\u2019s disease. Clin. Epigenetics 13, 1\u20134 (2021).","journal-title":"Clin. Epigenetics"},{"key":"568_CR116","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.parkreldis.2015.01.007","volume":"21","author":"SS Nielsen","year":"2015","unstructured":"Nielsen, S. S. et al. Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders. Parkinsonism Relat. Disord. 21, 355\u2013360 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"568_CR117","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.scitotenv.2018.07.143","volume":"645","author":"KC Paul","year":"2018","unstructured":"Paul, K. C. et al. Organophosphate pesticide exposure and differential genome-wide DNA methylation. Sci. Total Environ. 645, 1135\u20131143 (2018).","journal-title":"Sci. Total Environ."},{"key":"568_CR118","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-017-0090-8","volume":"6","author":"C Ma","year":"2017","unstructured":"Ma, C., Liu, Y., Neumann, S. & Gao, X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl. Neurodegener. 6, 18 (2017).","journal-title":"Transl. Neurodegener."},{"key":"568_CR119","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/ejhg.2016.175","volume":"25","author":"Y-H Chuang","year":"2017","unstructured":"Chuang, Y.-H. et al. Coffee consumption is associated with DNA methylation levels of human blood. Eur. J. Hum. Genet. 25, 608\u2013616 (2017).","journal-title":"Eur. J. Hum. Genet."},{"key":"568_CR120","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-012129","volume":"2","author":"SS Nielsen","year":"2012","unstructured":"Nielsen, S. S. et al. LINE-1 DNA methylation, smoking and risk of Parkinson\u2019s disease. J. Parkinson\u2019s Dis. 2, 303\u2013308 (2012).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"568_CR121","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fneur.2019.00148","volume":"10","author":"T Schirinzi","year":"2019","unstructured":"Schirinzi, T. et al. Dietary vitamin E as a protective factor for Parkinson\u2019s disease: clinical and experimental evidence. Front. Neurol. 10, 148 (2019).","journal-title":"Front. Neurol."},{"key":"568_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley, R. et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 17, 208 (2016).","journal-title":"Genome Biol."},{"key":"568_CR123","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1021\/bi00816a016","volume":"9","author":"H Hayatsu","year":"1970","unstructured":"Hayatsu, H., Wataya, Y., Kai, K. & Iida, S. Reaction of sodium bisulfite with uracil, cytosine, and their derivatives. Biochemistry 9, 2858\u20132865 (1970).","journal-title":"Biochemistry"},{"key":"568_CR124","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1126\/science.1220671","volume":"336","author":"MJ Booth","year":"2012","unstructured":"Booth, M. J. et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336, 934\u2013937 (2012).","journal-title":"Science"},{"key":"568_CR125","doi-asserted-by":"publisher","first-page":"18904","DOI":"10.1073\/pnas.1310240110","volume":"110","author":"AH Laszlo","year":"2013","unstructured":"Laszlo, A. H. et al. Detection and mapping of 5-methylcytosine and 5-hydroxymethylcytosine with nanopore MspA. Proc. Natl Acad. Sci. USA 110, 18904\u201318909 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"568_CR126","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuropharm.2013.12.019","volume":"80","author":"T Kato","year":"2014","unstructured":"Kato, T. & wamoto, K. Comprehensive DNA methylation and hydroxymethylation analysis in the human brain and its implication in mental disorders. Neuropharmacology 80, 133\u2013139 (2014).","journal-title":"Neuropharmacology"},{"key":"568_CR127","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1212\/WNL.0000000000002351","volume":"86","author":"X Gao","year":"2016","unstructured":"Gao, X., O\u2019Reilly, \u00c9. J., Schwarzschild, M. A. & Ascherio, A. Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology 86, 520\u2013526 (2016).","journal-title":"Neurology"},{"key":"568_CR128","doi-asserted-by":"publisher","first-page":"osad001","DOI":"10.1093\/exposome\/osad001","volume":"3","author":"ML Colwell","year":"2023","unstructured":"Colwell, M. L., Townsel, C., Petroff, R. L., Goodrich, J. M. & Dolinoy, D. C. Epigenetics and the exposome: DNA methylation as a proxy for health impacts of prenatal environmental exposures. Exposome 3, osad001 (2023).","journal-title":"Exposome"},{"key":"568_CR129","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41588-018-0193-x","volume":"50","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Qi, G., Park, J.-H. & Chatterjee, N. Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits. Nat. Genet. 50, 1318\u20131326 (2018).","journal-title":"Nat. Genet."},{"key":"568_CR130","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12859-019-2804-7","volume":"20","author":"S Graw","year":"2019","unstructured":"Graw, S., Henn, R., Thompson, J. A. & Koestler, D. C. pwrEWAS: a user-friendly tool for comprehensive power estimation for epigenome wide association studies (EWAS). BMC Bioinform. 20, 218 (2019).","journal-title":"BMC Bioinform."},{"key":"568_CR131","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/ije\/dyv041","volume":"44","author":"PC Tsai","year":"2015","unstructured":"Tsai, P. C. & Bell, J. T. Power and sample size estimation for epigenome-wide association scans to detect differential DNA methylation. Int. J. Epidemiol. 44, 1429 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"568_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-019-5761-7","volume":"20","author":"G Mansell","year":"2019","unstructured":"Mansell, G. et al. Guidance for DNA methylation studies: statistical insights from the Illumina EPIC array. BMC Genom. 20, 1\u201315 (2019).","journal-title":"BMC Genom."},{"key":"568_CR133","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1093\/bioinformatics\/btx435","volume":"33","author":"B Vieth","year":"2017","unstructured":"Vieth, B., Ziegenhain, C., Parekh, S., Enard, W. & Hellmann, I. powsimR: power analysis for bulk and single cell RNA-seq experiments. Bioinformatics 33, 3486\u20133488 (2017).","journal-title":"Bioinformatics"},{"key":"568_CR134","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1261\/rna.046011.114","volume":"20","author":"T Ching","year":"2014","unstructured":"Ching, T., Huang, S. & Garmire, L. X. Power analysis and sample size estimation for RNA-Seq differential expression. RNA 20, 1684 (2014).","journal-title":"RNA"},{"key":"568_CR135","doi-asserted-by":"publisher","unstructured":"Therneau, T. M. & Hart, S. Calculating samplesSize estimates for RNA Seq studies. https:\/\/doi.org\/10.18129\/B9.bioc.RNASeqPower (2022).","DOI":"10.18129\/B9.bioc.RNASeqPower"},{"key":"568_CR136","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath, S. DNA methylation age of human tissues and cell type. Genome Biol. 14, R115 (2013).","journal-title":"Genome Biol."},{"key":"568_CR137","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1289\/ehp.1509834","volume":"124","author":"X Zhu","year":"2016","unstructured":"Zhu, X. et al. Genome-wide analysis of DNA methylation and cigarette smoking in a Chinese population. Environ. health Perspect. 124, 966\u2013973 (2016).","journal-title":"Environ. health Perspect."},{"key":"568_CR138","doi-asserted-by":"publisher","first-page":"e63812","DOI":"10.1371\/journal.pone.0063812","volume":"8","author":"S Zeilinger","year":"2013","unstructured":"Zeilinger, S. et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS ONE 8, e63812 (2013).","journal-title":"PLoS ONE"},{"key":"568_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-020-00841-5","volume":"12","author":"ZE Reed","year":"2020","unstructured":"Reed, Z. E., Suderman, M. J., Relton, C. L., Davis, O. S. P. & Hemani, G. The association of DNA methylation with body mass index: Distinguishing between predictors and biomarkers. Clin. Epigenetics 12, 1\u201313 (2020).","journal-title":"Clin. Epigenetics"},{"key":"568_CR140","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/s41366-018-0262-3","volume":"43","author":"OKL Hamilton","year":"2019","unstructured":"Hamilton, O. K. L. et al. An epigenetic score for BMI based on DNA methylation correlates with poor physical health and major disease in the Lothian Birth Cohort. Int. J. Obes. 43, 1795\u20131802 (2019).","journal-title":"Int. J. Obes."},{"key":"568_CR141","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41586-019-1700-7","volume":"574","author":"P Mews","year":"2019","unstructured":"Mews, P. et al. Alcohol metabolism contributes to brain histone acetylation. Nature 574, 717\u2013721 (2019).","journal-title":"Nature"},{"key":"568_CR142","doi-asserted-by":"publisher","first-page":"e13006","DOI":"10.1111\/adb.13006","volume":"26","author":"MJ Longley","year":"2021","unstructured":"Longley, M. J., Lee, J., Jung, J. & Lohoff, F. W. Epigenetics of alcohol use disorder\u2014a review of recent advances in DNA methylation profiling. Addiction Biol. 26, e13006 (2021).","journal-title":"Addiction Biol."},{"key":"568_CR143","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrg3142","volume":"13","author":"R Feil","year":"2012","unstructured":"Feil, R. & Fraga, M. F. Epigenetics and the environment: emerging patterns and implications. Nat. Rev. Genet. 13, 97\u2013109 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"568_CR144","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","volume":"571","author":"G Cavalli","year":"2019","unstructured":"Cavalli, G. & Heard, E. Advances in epigenetics link genetics to the environment and disease. Nature 571, 489\u2013499 (2019).","journal-title":"Nature"},{"key":"568_CR145","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.mehy.2008.10.039","volume":"73","author":"AB Csoka","year":"2009","unstructured":"Csoka, A. B. & Szyf, M. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med. Hypotheses 73, 770\u2013780 (2009).","journal-title":"Med. Hypotheses"},{"key":"568_CR146","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pharmtox-030220-022920","volume":"61","author":"M Toth","year":"2021","unstructured":"Toth, M. Epigenetic neuropharmacology: drugs affecting the epigenome in the brain. Annu. Rev. Pharm. Toxicol. 61, 181\u2013201 (2021).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"568_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-021-01077-7","volume":"13","author":"J Cao","year":"2021","unstructured":"Cao, J. et al. The role of DNA methylation in syndromic and non-syndromic congenital heart disease. Clin. Epigenetics 13, 1\u201318 (2021).","journal-title":"Clin. Epigenetics"},{"key":"568_CR148","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cmet.2019.03.009","volume":"29","author":"C Ling","year":"2019","unstructured":"Ling, C. & R\u00f6nn, T. Epigenetics in human obesity and type 2 diabetes. Cell Metab. 29, 1028 (2019).","journal-title":"Cell Metab."},{"key":"568_CR149","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000503289","volume":"12","author":"E Barr\u00f3n-Cabrera","year":"2019","unstructured":"Barr\u00f3n-Cabrera, E. et al. Epigenetic modifications as outcomes of exercise interventions related to specific metabolic alterations: a systematic review. Lifestyle Genomics 12, 25\u201344 (2019).","journal-title":"Lifestyle Genomics"},{"key":"568_CR150","unstructured":"United States Geological Survey (USGS). National Water-Quality Assessment (NAWQA) Project. https:\/\/water.usgs.gov\/nawqa (1999)."},{"key":"568_CR151","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.3390\/ijerph15122885","volume":"15","author":"M Caballero","year":"2018","unstructured":"Caballero, M. et al. Estimated residential exposure to agricultural chemicals and premature mortality by Parkinson\u2019s disease in washington state. Int. J. Environ. Res. Public Health 15, 2885 (2018).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"568_CR152","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41370-020-0259-6","volume":"30","author":"L Chatzidiakou","year":"2020","unstructured":"Chatzidiakou, L. et al. Using low-cost sensor technologies and advanced computational methods to improve dose estimations in health panel studies: results of the AIRLESS project. J. Expo. Sci. Environ. Epidemiol. 30, 981\u2013989 (2020).","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"568_CR153","doi-asserted-by":"publisher","first-page":"e73138","DOI":"10.7554\/eLife.73138","volume":"11","author":"B Antal","year":"2022","unstructured":"Antal, B. et al. Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses. eLife 11, e73138 (2022).","journal-title":"eLife"},{"key":"568_CR154","doi-asserted-by":"publisher","first-page":"157838","DOI":"10.1016\/j.scitotenv.2022.157838","volume":"849","author":"R Li","year":"2022","unstructured":"Li, R. et al. Ambient air pollution, lifestyle, and genetic predisposition associated with type 2 diabetes: findings from a national prospective cohort study. Sci. Total Environ. 849, 157838 (2022).","journal-title":"Sci. Total Environ."},{"key":"568_CR155","doi-asserted-by":"publisher","first-page":"e000262","DOI":"10.1136\/fmch-2019-000262","volume":"8","author":"MZI Chowdhury","year":"2020","unstructured":"Chowdhury, M. Z. I. & Turin, T. C. Variable selection strategies and its importance in clinical prediction modelling. Fam. Med. Community Health 8, e000262 (2020).","journal-title":"Fam. Med. Community Health"},{"key":"568_CR156","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/15592294.2015.1100786","volume":"10","author":"E Hannon","year":"2015","unstructured":"Hannon, E., Lunnon, K., Schalkwyk, L. & Mill, J. Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes. Epigenetics 10, 1024\u20131032 (2015).","journal-title":"Epigenetics"},{"key":"568_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0376-y","volume":"9","author":"PR Braun","year":"2019","unstructured":"Braun, P. R. et al. Genome-wide DNA methylation comparison between live human brain and peripheral tissues within individuals. Transl. Psychiatry 9, 47 (2019).","journal-title":"Transl. Psychiatry"},{"key":"568_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-022-00308-9","volume":"8","author":"A Chalazonitis","year":"2022","unstructured":"Chalazonitis, A., Rao, M. & Sulzer, D. Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson\u2019s disease. npj Parkinsons Dis. 8, 1\u201316 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"568_CR159","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00702-021-02445-6","volume":"129","author":"P Derkinderen","year":"2022","unstructured":"Derkinderen, P. et al. Gastrointestinal mucosal biopsies in Parkinson\u2019s disease: beyond alpha-synuclein detection. J. Neural Transm. (Vienna) 129, 1095\u20131103 (2022).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"568_CR160","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5056\/jnm17141","volume":"24","author":"HJ Lee","year":"2018","unstructured":"Lee, H. J. et al. Relation of enteric \u03b1-synuclein to gastrointestinal dysfunction in patients with Parkinson\u2019s disease and in neurologically intact subjects. J. Neurogastroenterol. Motil. 24, 469\u2013478 (2018).","journal-title":"J. Neurogastroenterol. Motil."},{"key":"568_CR161","doi-asserted-by":"publisher","first-page":"e1944","DOI":"10.1212\/WNL.0000000000207147","volume":"100","author":"A Iranzo","year":"2023","unstructured":"Iranzo, A. et al. Misfolded \u03b1-synuclein assessment in the skin and CSF by RT-QuIC in isolated REM sleep behavior disorder. Neurology 100, e1944\u2013e1954 (2023).","journal-title":"Neurology"},{"key":"568_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r31","volume":"15","author":"AE Jaffe","year":"2014","unstructured":"Jaffe, A. E. & Irizarry, R. A. Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol. 15, R31 (2014).","journal-title":"Genome Biol."},{"key":"568_CR163","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4161\/epi.23924","volume":"8","author":"J Guintivano","year":"2013","unstructured":"Guintivano, J., Aryee, M. J. & Kaminsky, Z. A. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics 8, 290\u2013302 (2013).","journal-title":"Epigenetics"},{"key":"568_CR164","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2105-13-86","volume":"13","author":"EA Houseman","year":"2012","unstructured":"Houseman, E. A. et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinform. 13, 86 (2012).","journal-title":"BMC Bioinform."},{"key":"568_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02126-9","volume":"21","author":"AE Teschendorff","year":"2020","unstructured":"Teschendorff, A. E., Zhu, T., Breeze, C. E. & Beck, S. EPISCORE: cell type deconvolution of bulk tissue DNA methylomes from single-cell RNA-Seq data. Genome Biol. 21, 1 (2020).","journal-title":"Genome Biol."},{"key":"568_CR166","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/bioinformatics\/btt090","volume":"29","author":"T Gong","year":"2013","unstructured":"Gong, T. & Szustakowski, J. D. DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data. Bioinformatics 29, 1083\u20131085 (2013).","journal-title":"Bioinformatics"},{"key":"568_CR167","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/bib\/bbz166","volume":"22","author":"M Dong","year":"2021","unstructured":"Dong, M. et al. SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references. Brief. Bioinformatics 22, 416\u2013427 (2021).","journal-title":"Brief. Bioinformatics"},{"key":"568_CR168","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fgene.2020.00392","volume":"11","author":"H Li","year":"2020","unstructured":"Li, H. et al. DeconPeaker, a deconvolution model to identify cell types based on chromatin accessibility in ATAC-seq data of mixture samples. Front. Genet. 11, 392 (2020).","journal-title":"Front. Genet."},{"key":"568_CR169","doi-asserted-by":"publisher","unstructured":"Murphy, K. B., Nott, A. & Marzi, S. J. CHAS, a deconvolution tool, infers cell type-specific signatures in bulk brain histone acetylation studies of brain disorders. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.09.06.459142 (2021).","DOI":"10.1101\/2021.09.06.459142"},{"key":"568_CR170","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/s41596-020-00472-3","volume":"16","author":"A Nott","year":"2021","unstructured":"Nott, A., Schlachetzki, J. C. M., Fixsen, B. R. & Glass, C. K. Nuclei isolation of multiple brain cell types for omics interrogation. Nat. Protoc. 16, 1629\u20131646 (2021).","journal-title":"Nat. Protoc."},{"key":"568_CR171","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2015.04.005","volume":"58","author":"AA Kolodziejczyk","year":"2015","unstructured":"Kolodziejczyk, A. A., Kim, J. K., Svensson, V., Marioni, J. C. & Teichmann, S. A. The technology and biology of single-cell RNA sequencing. Mol. Cell 58, 610\u2013620 (2015).","journal-title":"Mol. Cell"},{"key":"568_CR172","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nmeth.3035","volume":"11","author":"SA Smallwood","year":"2014","unstructured":"Smallwood, S. A. et al. Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. Nat. Methods 11, 817\u2013820 (2014).","journal-title":"Nat. Methods"},{"key":"568_CR173","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"568_CR174","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41587-021-00869-9","volume":"39","author":"M Bartosovic","year":"2021","unstructured":"Bartosovic, M., Kabbe, M. & Castelo-Branco, G. Single-cell CUT&Tag profiles histone modifications and transcription factors in complex tissues. Nat. Biotechnol. 39, 825\u2013835 (2021).","journal-title":"Nat. Biotechnol."},{"key":"568_CR175","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/gepi.22086","volume":"42","author":"A Saffari","year":"2018","unstructured":"Saffari, A. et al. Estimation of a significance threshold for epigenome-wide association studies. Genet. Epidemiol. 42, 20\u201333 (2018).","journal-title":"Genet. Epidemiol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00568-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00568-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00568-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:20:52Z","timestamp":1703031652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00568-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":175,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00568-z","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"assertion":[{"value":"8 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}